These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37872910)

  • 1. Evaluating the Efficacy and Safety of Therapeutic Interventions in Sjögren's Syndrome: A Systematic Review Literature.
    Cooley DE; Jaramillo AP; Muñoz Armijos KN
    Cureus; 2023 Sep; 15(9):e45751. PubMed ID: 37872910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
    Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
    EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of pharmacological interventions for Sjogren syndrome - A systematic review.
    Choudhary R; Reddy SS; Nagaraju R; Nagi R; Rathore P; Sen R
    J Clin Exp Dent; 2023 Jan; 15(1):e51-e63. PubMed ID: 36755678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unstimulated whole salivary flow in Sjögren's Syndrome: systematic literature review and meta-analysis.
    Martínez-Ceballos MA; Aguilera N; Garzón-González KC; Cajamarca-Baron J; Alzate-Granados JP; Rojas-Villarraga A
    Adv Rheumatol; 2021 Feb; 61(1):8. PubMed ID: 33536075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
    Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
    J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear Cytokine Levels in Sicca Syndrome-Related Dry Eye: A Meta-Analysis.
    Aljohani S; Jazzar A
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral lesions in Sjogren's syndrome: A systematic review.
    Serrano J; Lopez-Pintor RM; Gonzalez-Serrano J; Fernandez-Castro M; Casanas E; Hernandez G
    Med Oral Patol Oral Cir Bucal; 2018 Jul; 23(4):e391-e400. PubMed ID: 29924754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective.
    Cartee DL; Maker S; Dalonges D; Manski MC
    J Dent Hyg; 2015 Dec; 89(6):365-71. PubMed ID: 26684993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in diagnostics, treatments, and correlations between oral and ocular manifestations of Sjogren's syndrome.
    Choudhry HS; Hosseini S; Choudhry HS; Fatahzadeh M; Khianey R; Dastjerdi MH
    Ocul Surf; 2022 Oct; 26():75-87. PubMed ID: 35961534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Sjögren's autoantibodies found in fibromyalgia patients with sicca and/or xerostomia.
    Applbaum E; Lichtbroun A
    Autoimmun Rev; 2019 Feb; 18(2):199-202. PubMed ID: 30572137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Workshop on Oral Medicine VII: Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review.
    Gueiros LA; France K; Posey R; Mays JW; Carey B; Sollecito TP; Setterfield J; Woo SB; Culton D; Payne AS; Lodi G; Greenberg MS; De Rossi S
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):102-110. PubMed ID: 31140693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
    Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
    Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions.
    Nair JJ; Singh TP
    J Clin Exp Dent; 2017 Apr; 9(4):e584-e589. PubMed ID: 28469828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Dry oral and ocular manifestations and autoantibodies characteristic of primary Sjögren's syndrome in multiple sclerosis".
    Hora JSI; da Silva MCR; Braga CLS; Loureiro AM; Alves ATNN; Lourenço SQC; Vasconcelos CCF
    Mult Scler Relat Disord; 2022 Jun; 62():103783. PubMed ID: 35452962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren's syndrome. Controversies and progress.
    Fox RI
    Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjogren's syndrome due to immune checkpoint inhibitors (ICIs): Insights from a single-institution series and systematic review of the literature.
    Soliman A; Hassan R; Codreanu I; Plaxe SC; Dasanu CA
    J Oncol Pharm Pract; 2024 Aug; ():10781552241271753. PubMed ID: 39113536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.